...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: $1.65 printed.....more delivery failures, 4,000 this time
15:00:00 T 1.65 0.17 4,000 100 TSX 25 Odlum

New Message
Please login to post a reply